CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 120 filers reported holding CARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $19,000 | -75.3% | 1,568 | -75.0% | 0.00% | -66.7% |
| Q4 2017 | $77,000 | -43.8% | 6,272 | -37.3% | 0.00% | -40.0% |
| Q3 2017 | $137,000 | -20.8% | 10,000 | -11.1% | 0.01% | -16.7% |
| Q2 2017 | $173,000 | -37.3% | 11,248 | -25.0% | 0.01% | -45.5% |
| Q1 2017 | $276,000 | +98.6% | 14,992 | 0.0% | 0.01% | +83.3% |
| Q4 2016 | $139,000 | – | 14,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $47,864,000 | 31.00% |
| Chescapmanager LLC | 1,484,303 | $25,382,000 | 4.27% |
| Cypress Capital Management LLC (WY) | 179,920 | $3,077,000 | 3.07% |
| DAFNA Capital Management LLC | 371,033 | $6,345,000 | 1.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $10,715,000 | 0.98% |
| Prosight Management, LP | 86,965 | $1,487,000 | 0.64% |
| ETF MANAGERS GROUP, LLC | 901,714 | $15,419,000 | 0.55% |
| Carmignac Gestion | 2,065,153 | $35,314,000 | 0.49% |
| Ikarian Capital, LLC | 273,524 | $4,677,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $39,330,000 | 0.32% |